Sign up to save your podcasts
Or
Share AI, Molecules, and New Drug Development: A Forward-Looking Discussion by Scientist + Entrepreneur Episode 02
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AI, Molecules, and New Drug Development: A Forward-Looking Discussion by Scientist + Entrepreneur Episode 02
[Stanford Doctor's Technology Entrepreneurship 02]
As technical founders in the American biotech industry, Dr. Che and Dr. Janice frequently participate in various industry conferences and professional exchanges. Their extensive knowledge, keen insights, and hands-on experience will bring listeners high-quality information and unique perspectives that are rare domestically. This dialogue will not only showcase how AI technology drives innovation and breakthroughs in the field of biotechnology but also explore the profound impact of this revolutionary change on the entire healthcare industry.
"What You'll Hear"
(Episode 2)
02:06 How to integrate statistical mechanics models with AI technology to accelerate drug discovery
07:17 Current top companies and technologies in the AI + biopharmaceutical field
24:17 Different growth paths of AI companies developing biotech and Biotech companies extending AI technology
30:06 Challenges and opportunities: difficulties and future prospects in the development of AI technology
33:51 Interdisciplinary communication and talent cultivation in the AI + biopharmaceutical field
"Permanent Hosts"
Janice, the founder of N1 Life
"Special Guest"
Dr. Che Xing, Founder and CEO of YDS Pharmatech, AI Expert
Dr. Janice graduated from Stanford University and has nearly 15 years of study and work experience in the United States. Her academic accomplishments are impressive, with multiple top-tier academic papers and several international patents. Driven by a passion for biotechnology, Dr. Janice founded N1 Life in Silicon Valley. This innovative company focuses on developing cutting-edge drug delivery technologies, skillfully combining the latest molecular and computational technologies to design and develop new drug delivery vectors, aiming to empower the entire drug development industry.
Under Dr. Janice's leadership, N1 Life has garnered extensive support from Stanford University and has had the fortune to invite a member of the National Academy of Sciences as a co-founder, highlighting the company’s strong academic background and technical prowess.
Dr. Che, founded YDS Pharmatech in New York State, a company at the forefront of integrating AI with biotechnology. YDS Pharmatech focuses on applying the latest AI technology to a computational design platform for multi-specific drugs.
Under Dr. Che's leadership, the company has made significant achievements in AI-enhanced biophysical simulations, with related research published in top journals like Nature Chemical Biology. YDS Pharmatech's influence extends far beyond its origins. The company has launched several global collaborative projects, with business spanning the U.S. from New York to Boston to California, and further expanding to China, Japan, and South Korea. Currently, YDS Pharmatech has established close collaborations with multiple biotech and biopharmaceutical companies, including large enterprises like Mitsubishi Tanabe Pharma, and several emerging companies invested by prominent venture capital firms such as RA Capital and Atlas Ventures.
"Music"
Mozart, Minuet (Eine Kleine Nachtmusik, 3rd. mov)
"Find Us Here"
Listening Platforms: Xiaoyuzhou｜Ximalaya｜Bilibili
Overseas Platforms: Spotify｜YouTube
View all episodes
By Airdrop从天而降[Stanford Doctor's Technology Entrepreneurship 02]
As technical founders in the American biotech industry, Dr. Che and Dr. Janice frequently participate in various industry conferences and professional exchanges. Their extensive knowledge, keen insights, and hands-on experience will bring listeners high-quality information and unique perspectives that are rare domestically. This dialogue will not only showcase how AI technology drives innovation and breakthroughs in the field of biotechnology but also explore the profound impact of this revolutionary change on the entire healthcare industry.
"What You'll Hear"
(Episode 2)
02:06 How to integrate statistical mechanics models with AI technology to accelerate drug discovery
07:17 Current top companies and technologies in the AI + biopharmaceutical field
24:17 Different growth paths of AI companies developing biotech and Biotech companies extending AI technology
30:06 Challenges and opportunities: difficulties and future prospects in the development of AI technology
33:51 Interdisciplinary communication and talent cultivation in the AI + biopharmaceutical field
"Permanent Hosts"
Janice, the founder of N1 Life
"Special Guest"
Dr. Che Xing, Founder and CEO of YDS Pharmatech, AI Expert
Dr. Janice graduated from Stanford University and has nearly 15 years of study and work experience in the United States. Her academic accomplishments are impressive, with multiple top-tier academic papers and several international patents. Driven by a passion for biotechnology, Dr. Janice founded N1 Life in Silicon Valley. This innovative company focuses on developing cutting-edge drug delivery technologies, skillfully combining the latest molecular and computational technologies to design and develop new drug delivery vectors, aiming to empower the entire drug development industry.
Under Dr. Janice's leadership, N1 Life has garnered extensive support from Stanford University and has had the fortune to invite a member of the National Academy of Sciences as a co-founder, highlighting the company’s strong academic background and technical prowess.
Dr. Che, founded YDS Pharmatech in New York State, a company at the forefront of integrating AI with biotechnology. YDS Pharmatech focuses on applying the latest AI technology to a computational design platform for multi-specific drugs.
Under Dr. Che's leadership, the company has made significant achievements in AI-enhanced biophysical simulations, with related research published in top journals like Nature Chemical Biology. YDS Pharmatech's influence extends far beyond its origins. The company has launched several global collaborative projects, with business spanning the U.S. from New York to Boston to California, and further expanding to China, Japan, and South Korea. Currently, YDS Pharmatech has established close collaborations with multiple biotech and biopharmaceutical companies, including large enterprises like Mitsubishi Tanabe Pharma, and several emerging companies invested by prominent venture capital firms such as RA Capital and Atlas Ventures.
"Music"
Mozart, Minuet (Eine Kleine Nachtmusik, 3rd. mov)
"Find Us Here"
Listening Platforms: Xiaoyuzhou｜Ximalaya｜Bilibili
Overseas Platforms: Spotify｜YouTube